This study examines the causal links between pain susceptibility and AD progression, with a particular focus on lysophosphatidylcholine acyltransferase 2 (LPCAT2), a key enzyme involved in lipid metabolism and inflammation. This evidence concerns the gene LPCAT2 and Alzheimer disease.